March 26, 2017 9:14 PM ET

Biotechnology

Company Overview of Isto Biologics

Company Overview

Isto Biologics develops orthobiologic products for spine, orthopedics, and sports medicine. It offers InQu, a bone graft extender and substitute; Influx, a trabecular bone graft; CellPoint, a concentrated bone marrow aspirate system; NuQu, a cell-based therapy for disc regeneration; and RevaFlex, a regenerative cartilage technology. Its products are used by patients suffering from debilitating pain and loss of mobility. Isto Biologics was formerly known as ISTO Technologies, Inc. and changed its name to Isto Biologics in October 2016. The company was founded in 1997 and is based in St. Louis, Missouri with operations in Massachusetts.

1155 Olivette Executive Parkway

Suite 200

St. Louis, MO 63132

United States

Founded in 1997

Phone:

314-995-6049

Fax:

314-995-6025

Key Executives for Isto Biologics

Chief Executive Officer, President and Director
Age: 69
Co Founder and Chairman of the Board Emeritus
Chief Commercial Officer
Senior Director of Clinical Operations
Chief Scientific Officer
Compensation as of Fiscal Year 2016.

Isto Biologics Key Developments

Isto Biologics Presents at Canaccord Genuity2017 Musculoskeletal Conference, Mar-14-2017 03:00 PM

Isto Biologics Presents at Canaccord Genuity2017 Musculoskeletal Conference, Mar-14-2017 03:00 PM. Venue: Westin San Diego, San Diego, California, United States.

Isto Biologics Names George Dunbar as CEO

Isto Technologies has acquired Arteriocyte Medical Systems Inc. Isto Holdings will combine the two companies under the name Isto Biologics. Isto Technologies CEO George Dunbar will be the company's CEO.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
October 19, 2016
Arteriocyte Medical Systems, Inc.
Merger/Acquisition
June 13, 2016
Isto Biologics, Commercial Business
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Isto Biologics, please visit www.istobiologics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.